Adenovirus infections in hematopoietic stem cell transplant recipients

Clinical Infectious Diseases

Volumn 29, Issue 6, 1999, Pages 1494-1501

  Howard, Dianna S ^a,d   Phillips II, Gordon L ^a   Reece, Donna E ^a   Munn, Rita K ^a   Henslee Downey, Jean ^c   Pittard, Melissa ^b   Barker, Matthew ^b   Pomeroy, Claire ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c Division of Transplantation Medicine   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ADENOVIRUS; AGE; ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL; VIRUS CULTURE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PATHOGENESIS;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; KENTUCKY; MALE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0033396237     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313514     Document Type: Article

References (27)

1. 1. Wasserman R, August CS, Plotkin SA. Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 1988; 7:109-15.
2. 2. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev 1992; 5:262-74.
3. 3. Horowitz MS. Adenoviridae and their replication. In: Fields BN, Knipe DM, eds. Fundamental virology. 2d ed. New York: Raven Press, 1991:771-813.
4. 4. Carrigan DR. Adenovirus infections in immunocompromised patients. Am J Med 1987; 83:555-9.
5. 5. Baum SG. Adenovirus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1382-7.
6. 6. Cherry JD. Adenoviral infections. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3d ed. Philadelphia: WB Saunders, 1992: 1670-87.
7. 7. Blanke C, Clark C, Broun R, et al. Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. Am J Med 1995; 99:326-8.
8. 8. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone marrow transplantation. N Engl J Med 1985; 312:529-33.
9. 9. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169:775-81.
10. 10. Munoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 1998; 27:1194-200.
11. 11. Bruno B, Boeckh M, Davis C, Gooley T, Hackman RC. Adenovirus infections in patients undergoing bone marrow transplantation. Blood 1997; 90:1867a.
12. 12. Waid TH, Lucas BA, Amlot P, et al. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection. Am J Kidney Dis 1989; 14:61-70.
13. 13. Piedra PA. Adenoviruses. In: Patrick CC, ed. Infections in immunocompromised infants and children. New York: Churchill Livingstone, 1992: 662-8.
14. 14. Krisher KK, Menegus MA. Evaluation of three types of cell culture for recovery of adenovirus from clinical specimens. J Clin Microbiol 1987; 25:1323-4.
15. 15. Woods GL, Young A. Use of A-549 cells in a clinical virology laboratory. J Clin Microbiol 1988; 26:1026-8.
16. 16. Ginsberg HS. Adenoviruses. Am J Clin Pathol 1972; 57:771-6.
17. 17. Zahradnik JM, Spencer MJ, Porter DD. Adenovirus infection in the immunocompromised patient. Am J Med 1980; 68:725-32.
18. 18. Gold E. Adenoviruses. In: Wedgwood RJ, et al., eds. Infections in children. Philadelphia: Harper & Row, 1982:1347-51.
19. 19. Nelson CT, Englund JA. New approaches to the use of ribavirin. Semin Pediatr Infect Dis 1996; 7:114-20.
20. 20. Sidwell RW. In vitro and in vivo inhibition of DNA viruses by ribavirin. In: Smith RA, Knoght V, Smith JAD, eds. Clinical applications of ribavirin. New York: Academic Press, 1984:19-32.
21. 21. Paroni R, Del Puppo M, Borghi C, Sirtori CR, Galli Kienle M. Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers. Int J Clin Pharmacol Ther Toxicol 1989; 27:302-7.
22. 22. McCarthy AJ, Bergin M, DeSilva LM, Stevens M. Intravenous ribavirin therapy for disseminated adenovirus infection. Pediatr Infect Dis J 1995; 14:1003-4.
23. 23. Murphy GF, Wood DP Jr, McRoberts JW, Henslee-Downey PJ. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 1993; 149:565-6.
24. 24. Liles WC, Cushing H, Holt S, Bryan C, Hackman RC. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant 1993; 12:409-12.
25. 25. Cassano WF. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 7: 247-8.
26. 26. Buchdahl RM, Taylor P, Warner JO. Nebulised ribavirin for adenovirus pneumonia. Lancet 1985; 2:1070-1.
27. 27. Wulffraat NM, Geelen SPM, VanDijken PJ, et al. Recovery from adenovirus pneumonia in a severe combined immunodeficiency patient treated with intravenous ribavirin [letter]. Transplantation 1995; 59:927.